Clinical trials recruiting for HER2-low Breast Cancer
7
Recruiting trials
14
US states with sites
3
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 1 2Phase 2 1Not applicable 5
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| ALX148 | 1 |
| CGT6297 | 1 |
| Fam-Trastuzumab Deruxtecan-Nxki | 1 |
| TTX-MC138 | 1 |
| Trastuzumab deruxtecan | 1 |
| Trastuzumab-rezetecan Treatment Group | 1 |
| Tucatinib | 1 |
| Zanidatamab | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Arizona | 2 |
| Colorado | 2 |
| Florida | 2 |
| Texas | 2 |
| Alabama | 1 |
| California | 1 |
| Illinois | 1 |
| Massachusetts | 1 |
| Minnesota | 1 |
| Missouri | 1 |
| New Jersey | 1 |
| Tennessee | 1 |
Top cities
Tampa, Florida 2Aurora, Colorado 1Austin, Texas 1Birmingham, Alabama 1Boston, Massachusetts 1Chicago, Illinois 1Denver, Colorado 1East Brunswick, New Jersey 1Fairfax, Virginia 1Houston, Texas 1
Self-screener
Recruiting trials
- A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
- A Study to Assess the Effectiveness of Trastuzumab Deruxtecan in Chinese Breast Cancer Patients (REFRESH)
- Analysis of Exploring Optimized Sequential Treatment Strategies of Antibody-Drug Conjugates (ADCs) in HER2-Low-Expressing Breast Cancer
- Distribution of the Homologous Recombination-related (HRR) Genesmutationsand HRD in Breast Cancer
- Efficacy and Safety of Trastuzumab-rezetecan in HER2-Expressing Breast Cancer
- HER2-PET as a Precision Imaging Tool for Treatment With HER2-ADC in HER2-expressing mBC
- PRE-ISPY Phase I/II Oncology Platform Program
Related conditions
Trials recruiting for HER2-low Breast Cancer often also study these conditions. Each links to its own recruiting-trial list.
Breast cancer 2239HER2-positive breast cancer 75Triple-negative breast cancer 138Solid Tumor, Adult 38Solid Carcinoma 6Rectal Neoplasms 14Rectal cancer 152PR-positive Breast Cancer 3Minimal Residual Disease 6Metastatic Cancer 31
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for HER2-low Breast Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.